Spruce Biosciences Correlations
SPRB Stock | USD 0.39 0.01 2.50% |
The current 90-days correlation between Spruce Biosciences and Hookipa Pharma is 0.3 (i.e., Weak diversification). The correlation of Spruce Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Spruce Biosciences Correlation With Market
Good diversification
The correlation between Spruce Biosciences and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Spruce Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Spruce |
Moving together with Spruce Stock
0.61 | DNLI | Denali Therapeutics Buyout Trend | PairCorr |
0.64 | FOLD | Amicus Therapeutics | PairCorr |
0.63 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.61 | SHPH | Shuttle Pharmaceuticals | PairCorr |
Moving against Spruce Stock
0.39 | PRFX | Painreform | PairCorr |
0.36 | APLS | Apellis Pharmaceuticals | PairCorr |
0.35 | ACAD | ACADIA Pharmaceuticals | PairCorr |
0.71 | CPIX | Cumberland Pharmaceuticals | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Spruce Stock performing well and Spruce Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Spruce Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
INZY | 3.31 | (0.76) | 0.00 | 2.04 | 0.00 | 6.41 | 16.32 | |||
DAWN | 1.78 | (0.16) | 0.00 | (0.24) | 0.00 | 3.03 | 11.05 | |||
TERN | 2.98 | (0.48) | 0.00 | (0.90) | 0.00 | 5.17 | 26.61 | |||
ELDN | 4.00 | 1.07 | 0.24 | (4.56) | 3.70 | 10.98 | 28.12 | |||
HOOK | 3.01 | (1.12) | 0.00 | 12.96 | 0.00 | 6.85 | 22.36 | |||
XFOR | 7.40 | 1.08 | 0.08 | (2.11) | 10.63 | 26.42 | 67.48 | |||
ABOS | 3.49 | (0.36) | 0.00 | (1.46) | 0.00 | 7.52 | 28.07 | |||
VECT | 2.63 | 1.10 | 0.60 | 2.56 | 0.88 | 5.61 | 39.30 |